LegitScript certification means an independent third party has verified that a healthcare merchant — a telehealth company, online pharmacy, or clinic — meets its standards for legitimate practice: licensed clinicians, a licensed pharmacy actually dispensing the medication, and marketing that doesn't misrepresent what's being sold. It's not a government license and it doesn't grade clinical outcomes. For GLP-1 medications specifically, where a large share of what's marketed online is unlicensed or counterfeit, it's one of the few free, independent ways to check whether a provider is real before you hand over your health history and payment information.
The short answer
LegitScript is an independent certification and monitoring company (unaffiliated with the FDA or any state) that verifies healthcare merchants meet its standards for legitimate operation — real licensed prescribers, a real licensed pharmacy, and compliant marketing. It does not evaluate whether a specific medication works or approve any drug. You can look up any provider, including Pallas, in LegitScript's public certification database before you start an intake or enter payment information.
What does LegitScript certification actually verify?
LegitScript reviews a healthcare merchant against a published set of standards before granting certification, and continues to monitor certified merchants afterward. In practical terms, that review generally covers:
- Licensed prescribers. The clinicians reviewing intakes and writing prescriptions hold current, verifiable US medical licenses in the states where they practice.
- Licensed pharmacy fulfillment. The pharmacy that actually dispenses the medication — whether a retail pharmacy for an FDA-approved brand or a compounding pharmacy for a compounded preparation — is named and properly licensed, not an unverified or offshore source.
- No prescription, no medication. Certified merchants can't ship a prescription drug without a genuine clinician review; a payment form is not a substitute for one.
- Truthful marketing. Advertising and site copy can't misrepresent what's being sold — including overstating what a compounded preparation is or implying a false equivalence to an FDA-approved product.
What certification doesn't do is vouch for how well a specific medication works for you, or replace FDA approval of a drug. Those are separate questions, covered further down.
Why does this matter more for GLP-1 than for other categories?
GLP-1 medications sit in an unusual spot: real demand, real shortages in recent years, and a genuinely legal compounded pathway alongside the FDA-approved brands — a combination that also attracted a wave of sellers with none of the above. Unlicensed sites have sold semaglutide and tirzepatide labeled "for research use only," shipped vials with no prescription requirement at all, and marketed unapproved salt forms (like semaglutide sodium or semaglutide acetate) that aren't the form used in any FDA-approved product. None of that is compounding in the legitimate, regulated sense — it's selling a prescription drug outside the law. Because a legal compounded option genuinely exists, patients have a harder time telling a licensed compounding pharmacy apart from an unlicensed seller just by reading a website. Third-party certification exists precisely to make that distinction checkable.
Ready to check your eligibility?
Complete a short health questionnaire and a US-licensed clinician will review whether GLP-1 treatment is appropriate for you.
Start your intake →How do I actually check whether a provider is certified?
Go to LegitScript's public certification database and search the company name. A current, verified certification will show there — this is the same database compliance teams, payment processors, and search engines use, and it's free to search. Do this before an intake, not after payment: a certification badge displayed on a provider's own site is worth confirming independently, since a badge image alone can be copied by anyone. If a company claims certification but doesn't appear in the database, or the search turns up an expired or different listing, treat that as a real red flag rather than a technicality.
Does certification mean the medications themselves are FDA-approved?
No — certification and FDA approval answer different questions, and it's worth keeping them separate. LegitScript certification is about the merchant: are the prescribers licensed, is the pharmacy licensed, is the marketing honest. FDA approval is about a specific drug product: has it gone through the FDA's review of safety, efficacy, and manufacturing quality.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.
A LegitScript-certified provider can legitimately offer either or both: FDA-approved brand-name medications (Wegovy® and Ozempic® from Novo Nordisk; Zepbound® and Mounjaro® from Eli Lilly), and compounded semaglutide or tirzepatide prepared per-patient by a US-licensed compounding pharmacy under FDCA §503A when a clinician documents a patient-specific clinical rationale. Certification confirms the provider and pharmacy behind either option are real and licensed — it doesn't make the compounded preparation equivalent to the brand-name drug, and a certified provider won't claim otherwise. For the fuller regulatory comparison between the two, see our guide to compounded vs. brand-name GLP-1 medications.
What other red flags matter alongside certification?
Certification is a strong signal, but it's not the only thing worth checking. Alongside a LegitScript lookup:
- The provider can name its pharmacy. Ask, if it isn't already stated — a legitimate telehealth company can tell you which licensed pharmacy fills your prescription.
- A real health questionnaire comes before any prescribing decision, not just before checkout.
- No willingness to ship without a prescription, regardless of how the product is labeled.
- The pharmacy itself is separately checkable. The FDA's BeSafeRx tool lets you confirm a pharmacy is state-licensed, independent of the merchant's own certification.
None of these substitute for the others — they're each one piece of the same picture: a real clinician, a real pharmacy, and a company willing to be checked.
Is Pallas LegitScript certified?
Yes. Pallas is LegitScript Healthcare Merchant Certified, with certification granted June 8, 2026. You can verify that in LegitScript's public database the same way you'd check any other provider. Certification doesn't change how Pallas is required to describe its medications — compounded preparations are still described as compounded, not as equivalents of the FDA-approved brands — and eligibility for any medication, brand-name or compounded, is always determined by a US-licensed clinician reviewing your specific health history.
Frequently asked questions
No. LegitScript is an independent, private certification and monitoring company. It isn't affiliated with the FDA, DEA, or any state pharmacy board, though many payment processors, ad platforms, and search engines rely on its certifications when deciding who can legitimately sell healthcare products online.
No — they answer different questions. LegitScript certification verifies the merchant: licensed prescribers, a licensed pharmacy, and honest marketing. FDA approval is a separate process that evaluates a specific drug product's safety, efficacy, and manufacturing quality. A certified provider can legitimately offer FDA-approved brand-name medications, compounded preparations, or both — certification doesn't make a compounded preparation equivalent to an FDA-approved one.
Search the company name in LegitScript's public certification database, which is free to use. Do this independently rather than trusting a certification badge displayed on the provider's own site — a badge image can be copied by anyone, but the database listing can't be faked.
LegitScript monitors certified merchants on an ongoing basis, not just at the initial review, and can revoke certification if a merchant stops meeting its standards. That's why checking the live database matters more than trusting a static badge or a claim made in marketing copy — the database reflects current status.
Not necessarily — a provider could be entirely legitimate without this specific certification, since it's one voluntary program among several ways to verify licensure. But certification is a strong, easily checkable signal, and its absence is worth asking about directly: a legitimate provider can always name its licensed pharmacy and clinicians even without a LegitScript badge.
Yes. Pallas is LegitScript Healthcare Merchant Certified, with certification granted June 8, 2026, verifiable in LegitScript's public database. Certification doesn't change how Pallas describes its medications — compounded preparations are still described as compounded, not as equivalents of FDA-approved brands — and eligibility is always determined by a US-licensed clinician.
The bottom line
LegitScript certification verifies that a healthcare merchant has real licensed clinicians, a real licensed pharmacy, and marketing that doesn't misrepresent what it sells — it's an independent check on the provider, not an FDA approval of a specific drug. Look up any GLP-1 provider in LegitScript's public database before starting an intake, confirm the pharmacy separately if you want extra assurance, and remember that certification and FDA-approval status are two different questions worth keeping straight. For the full picture of how online GLP-1 prescribing works end to end, see our guide to getting a GLP-1 prescription online, or start with our GLP-1 treatment overview.
See if you qualify in a few minutes
Pallas's intake is asynchronous in most states — complete it by message, and a US-licensed clinician will let you know if GLP-1 treatment is appropriate for you.
Start your intake →Trademarks & disclosures
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Pallas is not affiliated with, endorsed by, or sponsored by either manufacturer, or by LegitScript. Brand-name GLP-1 medications dispensed through Pallas are cash-pay only and are not billed to insurance. Prescriptions — brand-name or compounded — are written only when a US-licensed clinician determines treatment is appropriate.